...
首页> 外文期刊>EXCLI Journal >Synthesis, preclinical evaluation and antidepressant activity of 5-substituted phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides
【24h】

Synthesis, preclinical evaluation and antidepressant activity of 5-substituted phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides

机译:5-取代的苯基-3-(噻吩-2-基)-4,5-二氢-1H-吡唑-1-碳硫酰胺的合成,临床前评价和抗抑郁活性

获取原文

摘要

A series of phenyl-3-(thiophen-2-yl)-4, 5-dihydro-1H-pyrazole-1-carbothioamides (TTa-TTg) were synthesized by the ring closure reaction of phenyl-1-(thiophen-2-yl) prop-2-en-1-ones with thiosemicarbazide in alcoholic basic medium. All the final derivatives were evaluated for their antidepressant and neurotoxicity screening. The structures of the compounds were characterized by IR, 1H NMR, 13C NMR, Mass and elemental analyses. Preclinical evaluation of the compounds were ascertained by in silico toxicity, blood-brain barrier and human oral absorption prediction. In this series, 5-(4-hydroxyphenyl)-3-(thiophen-2-yl)-4,5-dihydro-1Hpyrazole- 1 carbothioamide (TTg) reduced immobility time 61.17 and 62.05 % in both force swimming and tail suspension test respectively at 10 mg/kg dose level when compared to the standard Imipramine without influencing the baseline locomotion. Moreover it was observed that the titled scaffold possessing electron withdrawing chlorine atom in the 4th position of aromatic ring of the scaffold also showed good the antidepressant activity. In conclusion, the behavioural investigation revealed that thiophene based pyrazolines having a carbothioamide tail unit in the N1 position may be therapeutically useful as potential antidepressant medications.
机译:通过苯基-1-(噻吩-2-的开环反应)合成了一系列苯基-3-(噻吩-2-基)-4,5-二氢-1H-吡唑-1-碳硫酰胺(TTa-TTg)。 yl)丙-2-烯-1-酮与硫代氨基脲在酒精性碱性介质中。对所有最终衍生物的抗抑郁药和神经毒性进行了评估。化合物的结构通过IR,1 H NMR,13 C NMR,质量和元素分析来表征。通过计算机毒性,血脑屏障和人类口服吸收预测来确定化合物的临床前评价。在该系列中,在强制游泳和尾部悬架测试中,5-(4-羟苯基)-3-(噻吩-2-基)-4,5-二氢-1吡唑-1碳硫酰胺(TTg)减少了61.17和62.05%的固定时间与标准丙咪嗪相比,剂量分别为10 mg / kg,而不会影响基线运动。此外,观察到在支架的芳环的第4位上具有吸电子氯原子的标题支架也显示出良好的抗抑郁活性。总之,行为研究表明,在N1位具有甲硫酰胺尾基的噻吩基吡唑啉可能作为潜在的抗抑郁药在治疗上有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号